Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644871 · ClinicalTrials.gov registry record · NA
A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4% Hydroquinone in Women With Mild to Severe Full-face Hyperpigmentation
A NA study, sponsored by Revision Skincare.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT07644871 is a NA study that has completed, run by Revision Skincare. The registered enrollment target is 18 participants.
The verdict
NCT07644871, a NA study, has completed, sponsored by Revision Skincare.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This a short four-week pilot study to measure the efficacy and tolerance of two brightening serums (cosmetics) versus 4% hydroquinone. The study was conducted in two sites across the USA, one in PA and in one in CA. The goal was to run the pilot study in the summer to understand the role of these two potential brightening serums in helping the appearance of skin tone evenness.
Interventions
- OTHER Facial Cleanser
- OTHER Facial Moisturizer
- OTHER Sunscreen SPF 55
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2025-08-11 |
| Est. Completion | 2025-11-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07644871
The ClinicalTrials.gov registry entry for NCT07644871 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Facial Cleanser is the first listed.
NCT07644871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07644871 about?
NCT07644871 is a clinical study titled "A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4% Hydroquinone in Women With Mild to Severe Full-face Hyperpigmentation". This a short four-week pilot study to measure the efficacy and tolerance of two brightening serums (cosmetics) versus 4% hydroquinone. The study was conducted in two sites across the USA, one in PA and in one in CA. The goal was to run the pilot study in the summer to understand the role of these tw...
What is the current status of trial NCT07644871?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2025-08-11. Estimated completion is 2025-11-12.
What interventions are being tested in trial NCT07644871?
The interventions under investigation include: Facial Cleanser (OTHER), Facial Moisturizer (OTHER), Sunscreen SPF 55 (OTHER).
Who is sponsoring clinical trial NCT07644871?
This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.